StocksRunner logo
mail
search
 
menu
 
CRISPR Therapeutics
57.19
+1.69%
 
StocksRunner
  Overview  
  
StocksRunner
  Analysis  
  
StocksRunner
     Risks     
  
StocksRunner
  Rating  
  
StocksRunner
     Chart     
  
StocksRunner
  Analysts  
  
StocksRunner
  Street  
  
StocksRunner
  Sentiment  
  
StocksRunner
  Earnings  
  
StocksRunner
  Headlines  
 
Downgrades
 
 
 

CRSP

 

CRISPR Therapeutics

$57.19

 
+$0.95 | +1.69%
 
StocksRunner
  Overview  
  
StocksRunner
  Analysis  
  
StocksRunner
     Risks     
  
StocksRunner
  Rating  
  
StocksRunner
     Chart     
  
StocksRunner
  Analysts  
  
StocksRunner
  Street  
  
StocksRunner
  Sentiment  
  
StocksRunner
  Earnings  
  
StocksRunner
  Headlines  
 
 
Open
$ 56.08
 
 
MKT CAP
$ 4.86B
 
High
$ 58.49
 
 
VOL
$ 955.21K
 
Low
$ 55.93
 
 
AVG VOL
$ 1.44M
 
 
 

CRSP Stock Rating Review

 
lock  Login to display CRISPR Therapeutics (CRSP) recommendation from the last 90 days from financial news and social media.
 
 

CRSP Total Score

 
 

Strengths

CRSP Rewards

 Earnings are forecast to grow

CRSP Rewards

 Trading below its fair value

 
 

Chart

 
 

62.31

53.91

74.78

55.44

 
 
1month
3month
6month
1year
 
Total Return
CRSP
vs.
S&P500
 

 
1-week Return
-5.44%
 
-0.58%
 
 
5-week Return
-7.44%
 
+1.51%
 
 
10-week Return
+11.76%
 
+6.38%
 
 
 

CRSP Risk Level

 

This Indicator assigning CRSP risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
CRSP Risk Level
LOW
HIGH

Risk Volatility

 

CRSP has Low Risk Level

Click here to check what is your level of risk

 

CRSP Analysts Opinion

 

CRSP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

4.00
 

CRSP Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.00
 

CRSP Future Sentiment

 Earnings are forecast to grow

CRSP Future Sentiment

 Trading below its fair value

 
 

CRSP Analysts Opinion

CRSP Analysts opinion is negative and it remained unchanged from the past 3 months

 

CRSP Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
92%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
100%
100%
 

CRSP Street Opinion 

CRSP Street view is extremely ish and have positive views on the near-term outlook

 

CRSP Performance Sentiment

 
Sentiments overview associated with CRSP events and the stock performance.
 
92%
0%
Positive
Negative
12 out of 13
events present
0 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

CRSP Earnings

 

The TTM reflects 12-month period, providing review of CRSP financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
270
370
-
 
 
Cost of Revenue
135
130
110
+10.78%
 
 
Gross Profit
135
240
-110
-
 
 
Operating Exp
434
462
563
-12.20%
 
 
Operating Inc
-299
-223
-673
-
 
 
Other Inc Exp
84
72
23
+91.11%
 
 
EPS Growth
-
 
 

CRSP Financial Health

 

The company financial health has moderately improved over the past year, reflecting average market demand and somewhat effective business strategies. There have been noticeable gains in profitability and cost management, but there is still substantial room for growth and optimization.

 

Financial Score

 
2.85
 
 
Linked to CRSP
Total Score
Close Price
% Change

 

NBIX

Neurocrine Biosciences

N/A

145.38

+0.07%

 

GILD

Gilead Sciences

3.64

71.17

-1.71%

 

BNTX

BioNTech

3.50

85.50

-0.67%

 

BIIB

Biogen

3.44

224.29

-1.03%

 
 
 
Headlines
Last Modify
Price
% Change

 
Approvals
This Week
60.48
-3.62%
 
New Product
This Week
62.75
+9.21%
 
New Product
3 Weeks Ago
55.38
-2.21%
 
 
CRSP Latest Updates +
 
 
 
StocksRunner

Explore our CRSP Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CRSP Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CRSP Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
Top Banner
 
StocksRunner
  Overview  
  
StocksRunner
  Analysis  
  
StocksRunner
   Risks   
  
StocksRunner
  Rating  
  
StocksRunner
  Chart  
  
StocksRunner
  Analysts  
  
StocksRunner
  Street  
  
StocksRunner
  Sentiment  
  
StocksRunner
  Earnings  
  
StocksRunner
  Headlines  
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

CRSP Rewards

 Earnings are forecast to grow

CRSP Rewards

 Trading below its fair value

 
 
 

CRSP Risk Level

 
 
 

The Indicator assigning CRSP risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
CRSP Risk Level
LOW
HIGH

Risk Volatility

 

CRSP has Low Risk Level. Click here to check what is your level of risk

 
 
 
 
 

CRSP

 

CRISPR Therapeutics

$57.19

 
+$0.95 | +1.69%
 

 
Open
$ 56.08
 
 
MKT CAP
$ 4.86B
 
High
$ 58.49
 
 
VOL
$ 955.21K
 
Low
$ 55.93
 
 
AVG VOL
$ 1.44M
 
 
 

CRSP Stock Rating

 
lock  Login to view CRISPR Therapeutics (CRSP) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

62.31

53.91

74.78

55.44

 
 
1month
3month
6month
1year
 
Total Return
CRSP
vs.
S&P500
 

 
1-week Return
-5.44%
 
-0.58%
 
 
5-week Return
-7.44%
 
+1.51%
 
 
10-week Return
+11.76%
 
+6.38%
 
 
 

CRSP Analysts Opinion

 

CRSP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

4.00
 

CRSP Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.00
 

CRSP Future Sentiment

 Earnings are forecast to grow

CRSP Future Sentiment

 Trading below its fair value

 
 

CRSP Analysts Opinion

CRSP Analysts opinion is negative and it remained unchanged from the past 3 months

 

CRSP Street Consensus

 

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
92%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
100%
100%
 

CRSP Street Opinion 

CRSP Street view is extremely ish and have positive views on the near-term outlook

 
CRSP Performance Sentiment
 
Sentiments overview associated with CRSP events and the stock performance.
 
92%
0%
Positive
Negative
12 out of 13
events present
0 out of 13
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

CRSP Earnings

 

The TTM data reflects the most recent 12-month period, providing overview of CRSP financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
270
370
-
 
 
Cost of Revenue
135
130
110
+10.78%
 
 
Gross Profit
135
240
-110
-
 
 
Operating Exp
434
462
563
-12.20%
 
 
Operating Inc
-299
-223
-673
-
 
 
Other Inc Exp
84
72
23
+91.11%
 
 
EPS Growth
-
 
 

CRSP Financial Health

 

The company financial health has moderately improved over the past year, reflecting average market demand and somewhat effective business strategies. There have been noticeable gains in profitability and cost management, but there is still substantial room for growth and optimization.

 

Financial Score

 
2.85
 
Headlines
Last Modify
Price
% Change

 
Approvals
This Week
60.48
-3.62%
 
New Product
This Week
62.75
+9.21%
 
New Product
3 Weeks Ago
55.38
-2.21%
 
 
CRSP Latest Updates +
 
 
 
 
 

Score Analyzer

 
 
 
Based on 13 events in the last 90 days from financial news and social media. Last updated Jul 23, 2024 21:30 Wall St. time
 
 

CRSP Total Score

 
 
 
 
 
 
 
StocksRunner

Discover CRSP Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of CRSP. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CRSP Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRSP Stock trends

CRSP Stock performance

CRSP Stock analysis

CRSP investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker